Adenovirus Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-07-23
Clinical Trial Update: Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A) [Phase 1]
A Phase 1 trial of Viralym-A (Adenovirus-specific T lymphocytes) sponsored by AlloVir has been withdrawn for Adenovirus infection.